Eight Strategies for When a Patient Asks about Supplements and Other Pseudomedicine
February 18, 2019 | Strategic Insights for Ambulatory Care
Providers have an "ethical mandate" to protect patients who may be vulnerable to promotion of pseudomedicine, says the author of a January 25, 2019, viewpoint in JAMA. Pseudomedicine refers to treatments and interventions, such as dietary supplements promoting brain health, that exist within the law but lack credible data about their efficacy. This is a major issue related to treatment for neurodegenerative diseases, such as Alzheimer disease, the author said.